Page last updated: 2024-10-22

aristolochic acid i and 2019 Novel Coronavirus Disease

aristolochic acid i has been researched along with 2019 Novel Coronavirus Disease in 3 studies

aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.

Research Excerpts

ExcerptRelevanceReference
"AH has no obvious toxicity to mice and is relatively safe when it is used in the form of decoction."1.91Long-term oral administration of Asarum heterotropoides f. mandshuricum (Maxim.) Kitag. decoction and its aristolochic acid analogs do not cause renal toxicity in mice. ( Han, J; Li, C; Liang, A; Liu, C; Liu, M; Liu, S; Meng, J; Pan, C; Qin, S; Tang, X; Tian, J; Wang, F; Wang, L; Wang, Y; Yi, Y; Zhang, Y; Zhao, Y, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Mokos, M1
Bašić-Jukić, N1
Das, T1
Mukerjee, N1
Ghosh, A1
Lorenzo, JM1
Dhama, K1
Dey, A1
Liu, M1
Wang, L2
Qin, S1
Zhao, Y1
Liu, S1
Yi, Y1
Li, C1
Tian, J1
Liu, C1
Meng, J1
Wang, Y1
Zhang, Y1
Wang, F1
Pan, C1
Han, J1
Tang, X1
Liang, A1

Other Studies

3 other studies available for aristolochic acid i and 2019 Novel Coronavirus Disease

ArticleYear
IgA nephropathy following SARS-CoV-2 vaccination in a renal transplant recipient with a history of aristolochic acid nephropathy.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2022, Volume: 26, Issue:3

    Topics: Aristolochic Acids; COVID-19; COVID-19 Vaccines; Female; Glomerulonephritis, IGA; Humans; Kidney Tra

2022
Growing risk of aristolochic acid nephropathy in the era of COVID-19 - Correspondence.
    International journal of surgery (London, England), 2022, Volume: 108

    Topics: Aristolochic Acids; COVID-19; Humans; Kidney Diseases

2022
Long-term oral administration of Asarum heterotropoides f. mandshuricum (Maxim.) Kitag. decoction and its aristolochic acid analogs do not cause renal toxicity in mice.
    Journal of ethnopharmacology, 2023, May-10, Volume: 307

    Topics: Animals; Aristolochic Acids; Asarum; COVID-19; Humans; Kidney; Mice

2023